Search results
The Centers for Medicare & Medicaid Services (CMS) rule, Transparency Reports and Reporting of Physician Ownership or Investment Interests, also known as the Physician Payments Sunshine Act, requires applicable manufacturers of drugs, devices, biologicals, or medical supplies to annually report to the CMS certain payments or transfers of value ...
If you have any questions regarding the specific application of the Physician Payments Sunshine Act to you or to your organization, the ACC encourages you to consult an attorney. A comprehensive list of frequently asked questions about the Sunshine Act.
The Open Payments program is a national disclosure program that promotes a more transparent and accountable health care system. Open Payments houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians. Please note that CMS does not comment on ...
Oct 2, 2014 · The Physician Payments Sunshine Act (PPSA)--also known as section 6002 of the Affordable Care Act (ACA) of 2010--requires medical product manufacturers to disclose to the Centers for Medicare...
The Final Rule to implement the Physician Payment Sunshine Act—Section 6002 of the Patient Protection and Affordable Care Act (released on February 1) —will make information publicly available about payments or transfers of value to physicians and teaching hospitals (“covered recipients”) from applicable manufacturers and group purchasing organi...
Oct 17, 2019 · The Physician Payment Sunshine Act is designed to increase transparency around financial relationships in health care. Get the latest news and information about the Sunshine Act at the AMA. Medicare Physician Payment Transparency Catalog of Topics. Follow Topic. Clear Search. 2 MIN READ. Physician financial transparency reports (Sunshine Act)
Jan 22, 2009 · S. 301. To amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP. IN THE SENATE OF THE UNITED STATES. January 22, 2009.
